Sequence variants in patients with primary and acquired resistance to Ibrutinib in the phase 3 MCL3001 (RAY) trial
暂无分享,去创建一个
G. Lenz | J. Goldberg | M. Dreyling | S. Rule | S. Balasubramanian | C. Phelps | M. Schaffer | A. Rizo
暂无分享,去创建一个
G. Lenz | J. Goldberg | M. Dreyling | S. Rule | S. Balasubramanian | C. Phelps | M. Schaffer | A. Rizo